Find information on thousands of medical conditions and prescription drugs.

Vivelle

The estrogen patch is a delivery system for estradiol used as hormone replacement therapy to treat the symptoms of menopause, such as hot flashes and vaginal dryness, and to prevent osteoporosis. Originally marketed as Vivelle® (Novartis), it was discontinued in 2003 and reintroduced in a smaller form as Vivelle-Dot®. Although the estrogen is given transdermally rather than in the standard oral tablets, the estrogen patch carries similar risks and benefits as more conventional forms of estrogen-only hormone replacement therapy.

Administration

Applied to the skin (not breasts) twice weekly.

Home

Vagifem

Valcyte

Valine

Valium

Valstar

Valtrex

Vaniqa

Velcade

Velivet

Venlafaxine

Ventolin

Vepesid

Verapamil

Verelan

Vermox

Versed

Vfend

Viadur

Viagra

Vicoprofen

Vidarabine

Vidaza

Videx

Vioxx

Viread

Visine

Vistide

Visudyne

Vitaped

Vitrase

Vivelle

Volmax

Voltaren

Voriconazole

Vosol

Read more at Wikipedia.org

• [List your site here Free!]

Estrogen replacement patch - Products
From OB/GYN News, 8/1/02

The Vivelle-Dot (estradiol transdermal system) estrogen replacement patch has been approved in a new 0.025 mg/day dosage strength, and is indicated for the prevention of postmenopausal osteoporosis. This low-dose patch is to be applied twice weekly to the lower abdomen, and can be worn while exercising, swimming, or bathing. The original four dosage strengths of the Vivelle-Dot--0.0375, 0.05, 0.075, and 0.1 mg/day--will continue to be available. For more information, contact Novogyne Pharmaceuticals, 888-669-6682, www.novogyne.com.

Return to Vivelle

Home

Contact

Resources

Exchange Links

ebay